作者: S.K. Powell , J. Gregory , S. Akbarian , K.J. Brennand
DOI: 10.1016/J.MCN.2017.05.007
关键词:
摘要: CRISPR/Cas9 technology has transformed our ability to manipulate the genome and epigenome, from efficient genomic editing targeted localization of effectors specific loci. Through manipulation DNA- histone-modifying enzyme activities, activation or repression gene expression, targeting transcriptional regulators, role gene-regulatory epigenetic pathways in basic biology disease processes can be directly queried. Here, we discuss emerging CRISPR-based methodologies, with consideration neurobiological applications human induced pluripotent stem cell (hiPSC)-based models.